임상 추론: 반복적인 기도흡인이 발생한 67세 파킨슨증후군 여성

참고문헌 (13)

1. Bhidayasiri R, "Red flags phenotyping:a systematic review on clinical features in atypical parkinsonian disorders", Parkinsonism Relat Disord, 59, pp.82~92 (2019)
2. Greene P, "Progressive supranuclear palsy, corticobasal degeneration, and multiple system atrophy", Continuum (Minneap Minn), 25, pp.919~935 (2019)
3. Höglinger GU, "Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria", Mov Disord, 32, pp.853~864 (2017)
4. Kompoliti K, "Pharmacological therapy in progressive supranuclear palsy", Arch Neurol, 55, pp.1099~1102 (1998)
5. Birdi S, "Progressive supranuclear palsy diagnosis and confounding features:report on 16 autopsied cases", Mov Disord, 17, pp.1255~1264 (2002)
6. Coyle-Gilchrist IT, "Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes", Neurology, 86, pp.1736~1743 (2016)
7. Yoshida K, "Incipient progressive supranuclear palsy is more common than expected and may comprise clinicopathological subtypes: a forensic autopsy series", Acta Neuropathol, 133, pp.809~823 (2017)
8. Dugger BN, "Clinicopathological outcomes of prospectively followed normal elderly brain bank volunteers", J Neuropathol Exp Neurol, 73, pp.244~252 (2014)
9. Boxer AL, "New diagnostics and therapeutics for progressive supranuclear palsy", Lancet Neurol, 16, pp.552~563 (2017)
10. Respondek G, "The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases", Mov Disord, 29, pp.1758~1766 (2014)
11. Zalewski N, "FDG-PET in pathologically confirmed spontaneous 4R-tauopathy variants", J Neurol, 261, pp.710~716 (2014)
12. Testa D, "Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy", Neurol Sci, 22, pp.247~251 (2001)
13. Glasmacher SA, "Predictors of survival in progressive supranuclear palsy and multiple system atrophy: a systematic review and meta-analysis", J Neurol Neurosurg Psychiatry, 88, pp.402~411 (2017)

관련 논문AI추천